查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1729411

日本表观遗传学市场报告（按产品、技术、应用和地区）2025-2033

Japan Epigenetics Market Report by Product, Technology, Application, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 121 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2024 年，日本表观遗传学市场规模达 1.6 亿美元。展望未来， IMARC Group预计到 2033 年市场规模将达到 4.57 亿美元，2025-2033 年期间的成长率 (CAGR) 为 12.4%。癌症、糖尿病和心血管疾病等慢性疾病病例的不断增加，加上对治疗这些疾病的表观遗传学研究和诊断的需求不断增长，是推动市场发展的主要因素。

表观遗传学是指在不改变底层 DNA 序列的情况下发生的基因表现变化。它涉及 DNA 及其相关蛋白质结构的修改，可以打开或关闭基因，影响生物体的特性和发育。表观遗传机制包括 DNA 甲基化（将甲基添加到 DNA 上）和组蛋白修饰（改变细胞核中 DNA 的包装）。这些改变可能受到环境因素、生活方式选择甚至跨世代经验的影响。表观遗传学在胚胎髮育、细胞分化和基因活动调控等各种生物过程中扮演着至关重要的角色。它也对健康和疾病有影响，因为表观遗传学变化可能导致癌症、心血管疾病和精神健康障碍等疾病的发展。了解表观遗传学有可能阐明遗传学和环境之间的相互作用，提供对基因调控及其对健康和福祉的影响的洞察。

日本表观遗传学市场趋势：

近年来，日本的表观遗传学市场取得了显着成长，这主要归功于它有可能彻底改变人们对基因调控的理解及其在各个领域的影响。首先，次世代定序和高通量检测等技术的进步推动了表观遗传学市场的发展。这些工具使研究人员能够以前所未有的规模和精度分析 DNA 甲基化、组蛋白修饰和非编码 RNA 表现。此外，癌症、神经系统疾病和代谢疾病等复杂疾病的盛行率不断上升，推动了对錶观遗传学研究的需求。表观遗传改变与这些疾病的发展和进展有关，因此迫切需要有针对性的治疗和诊断工具。此外，人们对錶观遗传学在个人化医疗中的作用的认识不断提高，引起了製药公司的兴趣，进一步刺激了市场发展。此外，政府和私人对錶观遗传学研究的投资激增，促进了学术机构和生物技术公司之间的创新和合作。这项资金支持加速了表观遗传药物和诊断解决方案的开发。最后，临床环境中表观遗传检测的日益普及，加上人口老化，预计将在预测期内推动日本表观遗传学市场的发展。

日本表观遗传学市场区隔：

产品洞察：

  • 试剂
  • 套件
    • 晶片定序试剂盒
    • 全基因组扩增试剂盒
    • 亚硫酸氢盐转化试剂盒
    • RNA定序试剂盒
    • 其他的
  • 仪器
  • 酵素
  • 服务

技术洞察：

  • DNA甲基化
  • 组蛋白甲基化
  • 组蛋白乙酰化
  • 大型非编码RNA
  • MicroRNA修饰
  • 染色质结构

应用程式洞察：

  • 肿瘤学
    • 实体肿瘤
    • 液体肿瘤
  • 非肿瘤学
    • 发炎性疾病
    • 代谢性疾病
    • 传染病
    • 心血管疾病
    • 其他的

竞争格局：

市场研究报告也对竞争格局进行了全面的分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪表板和公司评估象限等竞争分析。此外，也提供了所有主要公司的详细资料。

本报告回答的关键问题：

  • 日本表观遗传学市场迄今表现如何？未来几年将如何表现？
  • COVID-19 对日本表观遗传学市场有何影响？
  • 日本表观遗传学市场依产品划分是怎样的？
  • 日本表观遗传学市场按技术分類的分布如何？
  • 日本表观遗传学市场根据应用程式如何划分？
  • 日本表观遗传学市场的价值链分为哪些阶段？
  • 日本表观遗传学的主要驱动因素和挑战是什么？
  • 日本表观遗传学市场的结构是怎么样的？主要参与者是谁？
  • 日本表观遗传学市场的竞争程度如何？

本报告回答的关键问题：

  • 日本表观遗传学市场迄今表现如何？未来几年将如何表现？
  • COVID-19 对日本表观遗传学市场有何影响？
  • 日本表观遗传学市场依产品划分是怎样的？
  • 日本表观遗传学市场按技术分類的分布如何？
  • 日本表观遗传学市场根据应用程式如何划分？
  • 日本表观遗传学市场的价值链分为哪些阶段？
  • 日本表观遗传学的主要驱动因素和挑战是什么？
  • 日本表观遗传学市场的结构是怎么样的？主要参与者是谁？
  • 日本表观遗传学市场的竞争程度如何？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：日本表观遗传学市场 - 简介

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争情报

第五章：日本表观遗传学市场格局

  • 历史与当前市场趋势（2019-2024）
  • 市场预测（2025-2033）

第六章：日本表观遗传学市场-细分：依产品

  • 试剂
    • 概述
  • 套件
    • 概述
    • 市场区隔
      • 晶片定序试剂盒
      • 全基因组扩增试剂盒
      • 亚硫酸氢盐转化试剂盒
      • RNA定序试剂盒
      • 其他的
  • 仪器
    • 概述
  • 酵素
    • 概述
  • 服务
    • 概述

第七章：日本表观遗传学市场-细分：依技术

  • DNA甲基化
    • 概述
  • 组蛋白甲基化
    • 概述
  • 组蛋白乙酰化
    • 概述
  • 大型非编码RNA
    • 概述
  • MicroRNA修饰
    • 概述
  • 染色质结构
    • 概述

第 8 章：日本表观遗传学市场 - 细分：按应用

  • 肿瘤学
    • 概述
    • 市场区隔
      • 实体肿瘤
      • 液体肿瘤
  • 非肿瘤学
    • 概述
    • 市场区隔
      • 发炎性疾病
      • 代谢性疾病
      • 传染病
      • 心血管疾病
      • 其他的

第九章：日本表观遗传学市场－竞争格局

  • 概述
  • 市场结构
  • 市场参与者定位
  • 最佳获胜策略
  • 竞争仪錶板
  • 公司评估象限

第十章：关键参与者简介

  • Company A
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company B
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company C
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company D
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company E
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events

第 11 章：日本表观遗传学市场 - 产业分析

  • 驱动因素、限制因素和机会
    • 概述
    • 驱动程式
    • 限制
    • 机会
  • 波特五力分析
    • 概述
    • 买家的议价能力
    • 供应商的议价能力
    • 竞争程度
    • 新进入者的威胁
    • 替代品的威胁
  • 价值链分析

第 12 章：附录

简介目录
Product Code: SR112025A18151

Japan epigenetics market size reached USD 160.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 457.0 Million by 2033, exhibiting a growth rate (CAGR) of 12.4% during 2025-2033. The escalating cases of chronic diseases such as cancer, diabetes, and cardiovascular diseases, coupled with the rising demand for epigenetic research and diagnostics to manage these conditions, are primarily driving the market.

Epigenetics refers to changes in gene expression that occur without alterations to the underlying DNA sequence. It involves modifications to the structure of DNA and its associated proteins, which can turn genes on or off, influencing an organism's traits and development. Epigenetic mechanisms include DNA methylation, where methyl groups are added to DNA, and histone modifications, which alter the packaging of DNA in the cell nucleus. These modifications can be influenced by environmental factors, lifestyle choices, and even experiences across generations. Epigenetics plays a crucial role in various biological processes, such as embryonic development, cellular differentiation, and the regulation of gene activity. It also has implications for health and disease, as epigenetic changes can contribute to the development of diseases like cancer, cardiovascular disease, and mental health disorders. Understanding epigenetics has the potential to shed light on the interplay between genetics and the environment, providing insights into gene regulations and their impact on health and well-being.

Japan Epigenetics Market Trends:

The epigenetics market in Japan has witnessed remarkable growth in recent years, primarily owing to its potential to revolutionize understanding of gene regulation and its implications in various fields. Firstly, advancements in technology, such as next-generation sequencing and high-throughput assays, have propelled the epigenetics market forward. These tools enable researchers to analyze DNA methylation, histone modifications, and non-coding RNA expression at an unprecedented scale and accuracy. Furthermore, the rising prevalence of complex diseases, including cancer, neurological disorders, and metabolic conditions, has driven the demand for epigenetic studies. Epigenetic alterations have been linked to the development and progression of these diseases, creating a pressing need for targeted therapies and diagnostic tools. Additionally, the growing awareness of the role of epigenetics in personalized medicine has sparked interest among pharmaceutical companies, further stimulating the market. Moreover, government and private investments in epigenetics research have surged, fostering innovation and collaboration among academic institutions and biotechnology firms. This financial support has accelerated the development of epigenetic drugs and diagnostic solutions. Lastly, the increasing adoption of epigenetic testing in clinical settings, coupled with a growing aging population, is expected to drive the epigenetics market in Japan during the forecast period.

Japan Epigenetics Market Segmentation:

Product Insights:

  • Reagents
  • Kits
    • Chip Sequencing Kit
    • Whole Genomic Amplification Kit
    • Bisulfite Conversion Kit
    • RNA Sequencing Kit
    • Others
  • Instruments
  • Enzymes
  • Services

Technology Insights:

  • DNA Methylation
  • Histone Methylation
  • Histone Acetylation
  • Large Non-Coding RNA
  • MicroRNA Modification
  • Chromatin Structures

Application Insights:

  • Oncology
    • Solid Tumors
    • Liquid Tumors
  • Non-Oncology
    • Inflammatory Diseases
    • Metabolic Diseases
    • Infectious Diseases
    • Cardiovascular Diseases
    • Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan epigenetics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan epigenetics market?
  • What is the breakup of the Japan epigenetics market on the basis of product?
  • What is the breakup of the Japan epigenetics market on the basis of technology?
  • What is the breakup of the Japan epigenetics market on the basis of application?
  • What are the various stages in the value chain of the Japan epigenetics market?
  • What are the key driving factors and challenges in the Japan epigenetics?
  • What is the structure of the Japan epigenetics market and who are the key players?
  • What is the degree of competition in the Japan epigenetics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Epigenetics Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Epigenetics Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan Epigenetics Market - Breakup by Product

  • 6.1 Reagents
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Forecast (2025-2033)
  • 6.2 Kits
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Segmentation
      • 6.2.3.1 Chip Sequencing Kit
      • 6.2.3.2 Whole Genomic Amplification Kit
      • 6.2.3.3 Bisulfite Conversion Kit
      • 6.2.3.4 RNA Sequencing Kit
      • 6.2.3.5 Others
    • 6.2.4 Market Forecast (2025-2033)
  • 6.3 Instruments
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2019-2024)
    • 6.3.3 Market Forecast (2025-2033)
  • 6.4 Enzymes
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2019-2024)
    • 6.4.3 Market Forecast (2025-2033)
  • 6.5 Services
    • 6.5.1 Overview
    • 6.5.2 Historical and Current Market Trends (2019-2024)
    • 6.5.3 Market Forecast (2025-2033)

7 Japan Epigenetics Market - Breakup by Technology

  • 7.1 DNA Methylation
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Forecast (2025-2033)
  • 7.2 Histone Methylation
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Forecast (2025-2033)
  • 7.3 Histone Acetylation
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2019-2024)
    • 7.3.3 Market Forecast (2025-2033)
  • 7.4 Large Non-Coding RNA
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2019-2024)
    • 7.4.3 Market Forecast (2025-2033)
  • 7.5 MicroRNA Modification
    • 7.5.1 Overview
    • 7.5.2 Historical and Current Market Trends (2019-2024)
    • 7.5.3 Market Forecast (2025-2033)
  • 7.6 Chromatin Structures
    • 7.6.1 Overview
    • 7.6.2 Historical and Current Market Trends (2019-2024)
    • 7.6.3 Market Forecast (2025-2033)

8 Japan Epigenetics Market - Breakup by Application

  • 8.1 Oncology
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2019-2024)
    • 8.1.3 Market Segmentation
      • 8.1.3.1 Solid Tumors
      • 8.1.3.2 Liquid Tumors
    • 8.1.4 Market Forecast (2025-2033)
  • 8.2 non-oncology
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2019-2024)
    • 8.2.3 Market Segmentation
      • 8.2.3.1 Inflammatory Diseases
      • 8.2.3.2 Metabolic Diseases
      • 8.2.3.3 Infectious Diseases
      • 8.2.3.4 cardiovascular diseases
      • 8.2.3.5 Others
    • 8.2.4 Market Forecast (2025-2033)

9 Japan Epigenetics Market - Competitive Landscape

  • 9.1 Overview
  • 9.2 Market Structure
  • 9.3 Market Player Positioning
  • 9.4 Top Winning Strategies
  • 9.5 Competitive Dashboard
  • 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

  • 10.1 Company A
    • 10.1.1 Business Overview
    • 10.1.2 Product Portfolio
    • 10.1.3 Business Strategies
    • 10.1.4 SWOT Analysis
    • 10.1.5 Major News and Events
  • 10.2 Company B
    • 10.2.1 Business Overview
    • 10.2.2 Product Portfolio
    • 10.2.3 Business Strategies
    • 10.2.4 SWOT Analysis
    • 10.2.5 Major News and Events
  • 10.3 Company C
    • 10.3.1 Business Overview
    • 10.3.2 Product Portfolio
    • 10.3.3 Business Strategies
    • 10.3.4 SWOT Analysis
    • 10.3.5 Major News and Events
  • 10.4 Company D
    • 10.4.1 Business Overview
    • 10.4.2 Product Portfolio
    • 10.4.3 Business Strategies
    • 10.4.4 SWOT Analysis
    • 10.4.5 Major News and Events
  • 10.5 Company E
    • 10.5.1 Business Overview
    • 10.5.2 Product Portfolio
    • 10.5.3 Business Strategies
    • 10.5.4 SWOT Analysis
    • 10.5.5 Major News and Events

11 Japan Epigenetics Market - Industry Analysis

  • 11.1 Drivers, Restraints and Opportunities
    • 11.1.1 Overview
    • 11.1.2 Drivers
    • 11.1.3 Restraints
    • 11.1.4 Opportunities
  • 11.2 Porters Five Forces Analysis
    • 11.2.1 Overview
    • 11.2.2 Bargaining Power of Buyers
    • 11.2.3 Bargaining Power of Suppliers
    • 11.2.4 Degree of Competition
    • 11.2.5 Threat of New Entrants
    • 11.2.6 Threat of Substitutes
  • 11.3 Value Chain Analysis

12 Appendix